Welcome to the Q4 edition of Global Health & Pharma Magazine 2022, providing you with all of the latest news and features from across the healthcare and pharmaceutical landscape. Q4 2022 There’s no denying how the health and pharma industry is one of the most innovative in the world, having over the past century played such a crucial role in the development of new and improved medicines to prevent and treat diseases, as well as enhance quality of life for so many. This unique, thriving industry continues to revolutionise healthcare by helping to tackle unmet medical needs. An example of a company doing just this is our cover feature, Elucent Medical, who deliver ground-breaking solutions that enable surgeons to provide individualised patient care, no matter how simple or complex, with great efficiency and effectiveness. It is an extraordinary company that continues to evolve and redefine the standards of care to improve patient lives, and we are delighted to be giving you an insight into its work. Overall, we are proud to bestow our awards upon a myriad of cuttingedge businesses as they end 2022 on a high. All of us at GHP wish you a restful and reflective festive season and a prosperous new year. We look forward to welcoming you back again for the Q1 issue. Rebecca Scotland, Editor Website: www.ghp-news.com AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.
RkJQdWJsaXNoZXIy MTQxNTg3MQ==